{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:44:13Z","timestamp":1782135853807,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T00:00:00Z","timestamp":1490313600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee (HK)","doi-asserted-by":"crossref","award":["473711"],"award-info":[{"award-number":["473711"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s10552-017-0873-3","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T09:33:39Z","timestamp":1490348019000},"page":"415-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pelvic inflammatory disease and the risk of ovarian cancer: a meta-analysis"],"prefix":"10.1007","volume":"28","author":[{"given":"Zhiyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.","family":"Colditz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britton","family":"Trabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"873_CR1","unstructured":"World Health Organization (2016) Global health estimates 2015: deaths by cause, age, sex, by country and by region, 2000\u20132015, Geneva. http:\/\/www.who.int\/healthinfo\/global_burden_disease\/GlobalCOD_method_2000_2015.pdf . Accessed 09 February 2017"},{"key":"873_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"873_CR3","first-page":"315","volume":"55","author":"PE Schwartz","year":"2003","unstructured":"Schwartz PE (2003) Diagnosis and treatment of epithelial ovarian cancer. Minerva Ginecol 55:315\u2013326","journal-title":"Minerva Ginecol"},{"issue":"3","key":"873_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bpobgyn.2011.12.006","volume":"26","author":"CG Trope","year":"2012","unstructured":"Trope CG, Kaern J, Davidson B (2012) Borderline ovarian tumours. Best Pract Res Clin Obstet Gynaecol 26(3):325\u2013336","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"873_CR5","unstructured":"National Cancer Institute (2016) Ovarian epithelial, fallopian tube, and primary peritoneal cancer Treatment (PDQ(R)): Health Professional Version. https:\/\/www.cancer.gov\/types\/ovarian\/hp\/ovarian-epithelial-treatment-pdq . Accessed 09 September 2016"},{"key":"873_CR6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","volume":"91","author":"RB Ness","year":"1999","unstructured":"Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459\u20131467","journal-title":"J Natl Cancer Inst"},{"key":"873_CR7","first-page":"447","volume":"4","author":"HA Risch","year":"1995","unstructured":"Risch HA, Howe GR (1995) Pelvic inflammatory disease and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 4:447\u2013451","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"873_CR8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.17772\/gp\/1579","volume":"84","author":"R Kisielewski","year":"2013","unstructured":"Kisielewski R, To\u0142wi\u0144ska A, Mazurek A, Lauda\u0144ski P (2013) Inflammation and ovarian cancer\u2013current views. Ginekol Pol 84:293\u2013297","journal-title":"Ginekol Pol"},{"key":"873_CR9","doi-asserted-by":"crossref","first-page":"djt431","DOI":"10.1093\/jnci\/djt431","volume":"106","author":"B Trabert","year":"2014","unstructured":"Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kj\u00e6r SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N; Ovarian Cancer Association Consortium (2014) Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the ovarian cancer association consortium. J Natl Cancer Inst 106:djt431","journal-title":"J Natl Cancer Inst"},{"key":"873_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","volume":"58","author":"A Macci\u00f2","year":"2012","unstructured":"Macci\u00f2 A, Madeddu C (2012) Inflammation and ovarian cancer. Cytokine 58:133\u2013147","journal-title":"Cytokine"},{"key":"873_CR11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Shih IeM (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2013shifting the paradigm. Hum Pathol 42:918\u2013931","journal-title":"Hum Pathol"},{"key":"873_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/1940-6207.CAPR-10-0266","volume":"4","author":"MS Yates","year":"2011","unstructured":"Yates MS, Meyer LA, Deavers MT, Daniels MS, Keeler ER, Mok SC (2011) Microscopic and early-stage ovarian cancers in BRCA1\/2 mutation carriers: building a model for early BRCA-associated tumorigenesis. Cancer Prev Res 4:463\u2013470","journal-title":"Cancer Prev Res"},{"key":"873_CR13","first-page":"667","volume":"5","author":"F Parazzini","year":"1996","unstructured":"Parazzini F, La Vecchia C, Negri E, Moroni S, dal Pino D, Fedele L (1996) Pelvic inflammatory disease and risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 5:667\u2013669","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"873_CR14","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","volume":"12","author":"HW Lin","year":"2011","unstructured":"Lin HW, Tu YY, Lin SY, Su WJ, Lin WL, Lin WZ, Wu SC, Lai YL (2011) Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol 12:900\u2013904","journal-title":"Lancet Oncol"},{"key":"873_CR15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/IGC.0000000000000235","volume":"24","author":"JN McAlpine","year":"2014","unstructured":"McAlpine JN, Lisonkova S, Joseph KS, McComb PF (2014) Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study. Int J Gynecol Cancer 24:1406\u20131413","journal-title":"Int J Gynecol Cancer"},{"key":"873_CR16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.idc.2008.05.008","volume":"22","author":"SM Lareau","year":"2008","unstructured":"Lareau SM, Beigi RH (2008) Pelvic inflammatory disease and tubo-ovarian abscess. Infect Dis Clin N Am 22:693\u2013708","journal-title":"Infect Dis Clin N Am"},{"key":"873_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","volume":"122","author":"MA Merritt","year":"2008","unstructured":"Merritt MA, Green AC, Nagle CM, Webb PM, Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group (2008) Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer 122:170\u2013176","journal-title":"Int J Cancer"},{"key":"873_CR18","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/ijc.24091","volume":"124","author":"AH Wu","year":"2009","unstructured":"Wu AH, Pearce CL, Tseng CC, Templeman C, Pike MC (2009) Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer 124:1409\u20131415","journal-title":"Int J Cancer"},{"key":"873_CR19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2012.10.023","volume":"128","author":"LM Stewart","year":"2013","unstructured":"Stewart LM, Holman CD, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R (2013) In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol 128:260\u2013264","journal-title":"Gynecol Oncol"},{"key":"873_CR20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1055-9965.EPI-16-0459","volume":"26","author":"CB Rasmussen","year":"2017","unstructured":"Rasmussen CB, Jensen A, Albieri V, Andersen KK, Kjaer SK (2017) Is pelvic inflammatory disease a risk factor for ovarian cancer? Cancer Epidemiol Biomarkers Prev 26:104\u2013109","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"873_CR21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10552-013-0216-y","volume":"24","author":"CB Rasmussen","year":"2013","unstructured":"Rasmussen CB, Faber MT, Jensen A, Hogdall E, Hogdall C, Blaakaer J, Kjaer SK (2013) Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors. Cancer Causes Control 24:1459\u20131464","journal-title":"Cancer Causes Control"},{"key":"873_CR22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/s12885-016-2857-1","volume":"16","author":"CC Shen","year":"2016","unstructured":"Shen CC, Hu LY, Yang AC, Chiang YY, Hung JH, Tsai SJ (2016) Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study. BMC Cancer 16:839","journal-title":"BMC Cancer"},{"key":"873_CR23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ygyno.2016.08.318","volume":"143","author":"CB Rasmussen","year":"2016","unstructured":"Rasmussen CB, Jsensen A, Albieri V, Andersen KK, Kjaer SK (2016) Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study. Gynecol Oncol 143:346\u2013351","journal-title":"Gynecol Oncol"},{"key":"873_CR24","first-page":"3670","volume":"49","author":"XO Shu","year":"1989","unstructured":"Shu XO, Brinton LA, Gao YT, Yuan JM (1989) Population-based case\u2013control study of ovarian cancer in Shanghai. Cancer Res 49:3670\u20133674","journal-title":"Cancer Res"},{"key":"873_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00001648-200003000-00006","volume":"11","author":"RB Ness","year":"2000","unstructured":"Ness RB, Grisso JA, Cottreau C, Klapper J, Vergona R, Wheeler JE, Morgan M, Schlesselman JJ (2000) Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer. Epidemiology 11:111\u2013117","journal-title":"Epidemiology"},{"key":"873_CR26","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P (2011) The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp . Accessed 18 June 2016"},{"key":"873_CR27","unstructured":"Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). The cochrane collaboration, 2011. http:\/\/www.handbook.cochrane.org . Accessed 08 August 2016"},{"key":"873_CR28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188","journal-title":"Control Clin Trials"},{"key":"873_CR29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"873_CR30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"873_CR31","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","volume":"54","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046\u20131055","journal-title":"J Clin Epidemiol"},{"key":"873_CR32","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"873_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","volume":"185","author":"CB Rasmussen","year":"2016","unstructured":"Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, H\u00f8gdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, Schildkraut JM, Berchuck A, Olson SH, Kiemeney LA, Massuger LF, Narod SA, Phelan CM, Anton-Culver H, Ziogas A, Wu AH, Pearce CL, Risch HA, Jensen A; on behalf of the Ovarian Cancer Association Consortium. (2016) Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case\u2013control studies. Am J Epidemiol 185:8\u201320.","journal-title":"Am J Epidemiol"},{"key":"873_CR34","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","volume":"121","author":"SP Hussain","year":"2007","unstructured":"Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121:2373\u20132380","journal-title":"Int J Cancer"},{"key":"873_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-3-25","volume":"3","author":"X Wang","year":"2005","unstructured":"Wang X, Wang E, Kavanagh JJ, Freedman RS (2005) Ovarian cancer, the coagulation pathway, and inflammation. J Transl Med 3:25","journal-title":"J Transl Med"},{"key":"873_CR36","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","volume":"136","author":"AS Whittemore","year":"1992","unstructured":"Whittemore AS, Harris R, Itnyre J, Collaborative Ovarian Cancer Group (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case\u2013control studies. II. Invasive epithelial ovarian cancers in white women.. Am J Epidemiol 136:1184\u20131203","journal-title":"Am J Epidemiol"},{"key":"873_CR37","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00404-016-4172-0","volume":"294","author":"LY Wang","year":"2016","unstructured":"Wang LY, OuYang L, Tong F, Zhang XJ, Li XD, Wang CC, Li X, Sun L, Sun YH (2016) The effect of contraceptive methods on reproductive tract infections risk: a cross-sectional study having a sample of 52,481 women. Arch Gynecol Obstet 294:1249\u20131256","journal-title":"Arch Gynecol Obstet"},{"key":"873_CR38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.0001-6349.2004.00550.x","volume":"83","author":"T Riman","year":"2004","unstructured":"Riman T, Nilsson S, Persson IR (2004) Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 83:783\u2013795","journal-title":"Acta Obstet Gynecol Scand"},{"key":"873_CR39","first-page":"169","volume":"18","author":"J He","year":"2009","unstructured":"He J, Gao X, Ren Z (2009) Global Incidence patterns of female breast and ovarian cancers. China Cancer 18:169\u2013172","journal-title":"China Cancer"},{"key":"873_CR40","first-page":"151","volume":"8","author":"AL Beavis","year":"2016","unstructured":"Beavis AL, Smith AJ, Fader AN (2016) Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health 8:151\u2013167","journal-title":"Int J Womens Health"},{"key":"873_CR41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/01.PSN.0000290280.48197.e7","volume":"27","author":"M Marshall","year":"2007","unstructured":"Marshall M, Solomon S (2007) Hereditary breast-ovarian cancer: clinical findings and medical management. Plast Surg Nurs 27:124\u2013127","journal-title":"Plast Surg Nurs"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0873-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-017-0873-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-017-0873-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:49:16Z","timestamp":1589741356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-017-0873-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["873"],"URL":"https:\/\/doi.org\/10.1007\/s10552-017-0873-3","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]}}}